Joseph Edelman, 10% Owner at VYNE Therapeutics Inc. (VYNE), sold 250,000 shares at $1.74 ($435K) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Open-market sale of $435k VYNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |